Since both RARβ2 and CYP26A1 gene expression was not detectable without aRA treatment in all aRA-sensitive and -resistant cancer cells tested, we did not carry out RARβ2 siRNA transfection experiments without treatment with aRA. This evidence concerns the gene CYP26A1 and cancer.